Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib-MedSci.cn - 梅斯（MedSci）

Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib

Patel, AA; Cahill, K; Charnot-Katsikas, A; Liu, HT; Gurbuxani, S; Thirman, M; Kosuri, S; Artz, AS; Larson, RA; Stock, W; Segal, J; Odenike, O

Odenike, O (corresponding author), Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA.

BRITISH JOURNAL OF HAEMATOLOGY, 2020; 190 (1): E48

科室
- - 订阅+
  - 更多科室
工具
服务